Literature DB >> 15166428

Nef from a primary isolate of human immunodeficiency virus type 1 lacking the EE(155) region shows decreased ability to down-regulate CD4.

Young-Soon Na1, Keejung Yoon1, Jeong-Gu Nam2, Byeongsun Choi2, Joo-Shil Lee2, Ikunoshin Kato3, Sunyoung Kim1.   

Abstract

The human immunodeficiency virus (HIV) nef gene encodes a 27 kDa myristoylated cytosolic protein that has an important role in the pathogenesis of AIDS. One function of Nef is the down-regulation of CD4 and MHC class I surface molecules in HIV-infected cells. Nef directly isolated from an infected individual (KS2), who could be defined as a long-term non-progressor, was compared with Nef from a standard laboratory strain, HIV-1 NL4-3. KS2 Nef protein was characterized by its lowered ability to down-regulate CD4, while still maintaining the ability to down-regulate MHC class I. The ability of KS2 Nef to down-regulate CD4 was more prominent when CD4 was measured 2-3 days after transfer of the nef gene to the target cells, and also when the effect was measured in CD4(+)-enriched primary T cells. The amino acid sequence analysis indicated that the most notable feature of KS2 Nef was lack of the two glutamic acids: the EE(155) region. When the EE(155) region was added to KS2 Nef, the CD4 down-regulation ability was increased almost to the level of NL4-3 Nef. Conversely, when the EE(155) region was deleted from NL4-3, its CD4 down-regulation ability was dramatically impaired. These data suggested that the EE(155) region plays an important role(s) in the down-regulation of CD4 by Nef protein and also that primary nef sequences could be very useful in identifying the original biological functions of Nef in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166428     DOI: 10.1099/vir.0.79803-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Intra- and intersubtype alternative Pak2-activating structural motifs of human immunodeficiency virus type 1 Nef.

Authors:  Eduardo O'Neill; Laura L Baugh; Vladimir A Novitsky; Myron E Essex; J Victor Garcia
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Dynamics of physical interaction between HIV-1 Nef and ASK1: identifying the interacting motif(s).

Authors:  Balawant Kumar; Chakrapani Tripathi; Ranjana K Kanchan; Jitendra Kumar Tripathi; Jimut K Ghosh; Ravishankar Ramachandran; Smrati Bhadauria; Raj Kamal Tripathi
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

3.  In-silico designing of a potent analogue against HIV-1 Nef protein and protease by predicting its interaction network with host cell proteins.

Authors:  Shikha Pal; Madhur Mishra; D Raja Sudhakar; Mohammed Haris Siddiqui
Journal:  J Pharm Bioallied Sci       Date:  2013-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.